Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Assembly Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 54 | 54 | 0 |
| Shares | 19.1M | 17.2M | −1.89M (−9.9%) |
| Value | $39.3M | $36.1M | −$3.20M (−8.2%) |
New holders (6)
Institutions that held Assembly Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 62,438 | $131.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 28,961 | $61.0K | 0.00% |
| Engineers Gate Manager LP | 19,134 | $40.0K | 0.00% |
| Prudential Financial Inc | 16,980 | $36.0K | 0.00% |
| XTX Topco Ltd | 13,207 | $28.0K | 0.01% |
| Simplex Trading, LLC | 5,686 | $11.0K | 0.00% |
Sold out (6)
Institutions that held Assembly Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 2,000,000 | $4.12M |
| Eversept Partners, LP | 280,000 | $576.8K |
| Ikarian Capital, LLC | 227,076 | $468.0K |
| Gsa Capital Partners LLP | 135,834 | $280.0K |
| Boothbay Fund Management, LLC | 21,408 | $44.0K |
| Bridgefront Capital, LLC | 10,137 | $21.0K |